They didn't pause it because they're considering cancelling it. They're pausing it so they can communicate to patients and providers what to look out for after they take it. Once processes are in place to handle future blood clot events, they will resume vaccinations.
I’ve been thinking about this, the communication has been so bad from public and private health officials for 15 months straight.
When not considering any externalities, anti-vaxxers and everyone that comes up with anti-industry and anti-establishment conclusions is rational, but inaccurate only because they dont consider what was not said.
Even with regard to COVID itself, most of the official communication is about avoiding death when the reality is that its not about only avoiding death its about all the additional debilitating effects in the vast “recovered” statistic, so it is rational to decide to ignore that once you do your own math and noticing who is actually dying. But it is not accurate because it doesn't factor in the unsaid aspect.
The reason for the pause was explicitly stated by the health officials as quoted in the article, so I don't know why you'd say this was unclear let alone unsaid.
They might also add additional guidelines for who is eligible for J&J. A bunch of countries have set a minimum age for AZ vaccine, I could see something similar happening here with J&J. Perhaps excluding women under 50 for example.
But I agree J&J will definitely resume in some capacity in the near-ish future.
